Human RIPK3 (Receptor-interacting serine/threonine-protein kinase 3) ELISA Kit (HUFI04910)

RIPK3 is a serine/threonine kinase that acts as the central driver of necroptosis, a form of programmed necrotic cell death implicated in inflammatory disease, ischemic injury, and tumor biology. By phosphorylating the pseudokinase MLKL, RIPK3 triggers plasma membrane rupture and the subsequent release of pro-inflammatory intracellular contents, making it a focal target for basic research and drug discovery efforts.

Developed by Assay Genie for the quantitative measurement of human RIPK3 protein, this ELISA Kit is supplied as a 96 Assays microplate-format research reagent. The assay supports investigation of necroptosis signaling in cultured cell lysates and tissue homogenates, allowing researchers to monitor RIPK3 protein abundance in experimental models of inflammation, neurodegeneration, and oncology. Each kit is intended for in vitro research use only and includes the reagents needed to perform quantitative detection across a full microplate of samples.

Researchers studying the TNF-induced necroptosis pathway, necroptosis-related biomarkers, or the intersection of cell death with innate immune signaling will find this kit useful for profiling RIPK3 expression in disease models and treatment responses.